Parametres | Patients | Controls | p |
---|---|---|---|
Age (y) | 43.5 ± 10.7 | 40.4 ± 11.3 | > 0.05 |
Gender (F/M) | 73/53 | 20/16 | Â |
CRP (ng/ml) | 9.8 ± 4.3 | 3.5 ± 2.1 | < 0.001 |
Albumin (g/dl) | 2.5 ± 1.2 | 4.4 ± 1.1 | < 0.001 |
Midkine (ng/ml) | 0.21 ± 0.034 | 0.36 ± 0.1 | < 0.05 |
VEGF-A (pg/ml) | 629.3 ± 205.6 | 309.4 ± 135.8 | < 0.001 |
VEGF-C (pg/ml) | 3428.1 ± 987.5 | 1736.9 ± 685.8 | < 0.001 |
IL-1α (pg/ml) | 785.7 ± 243.9 | 209.6 ± 102.3 | < 0.001 |
IL-1β (pg/ml) | 693.9 ± 305.7 | 276.9 ± 132.2 | < 0.001 |
IL-6 (pg/ml) | 109.6 ± 45.8 | 34.9 ± 29.7 | < 0.0001 |
IL-8 (pg/ml) | 78.6 ± 25.4 | 29.5 ± 19.6 | < 0.001 |
IL-10 (pg/ml) | 5.7 ± 1.9 | 2.3 ± 1.1 | < 0.001 |
TNF-α (pg/ml) | 28 ± 14 | 10 ± 7 | < 0.001 |
Leptin (ng/ml) | 47.6 ± 10.3 | 23.8 ± 11.4 | < 0.001 |
Adiponectin (μg/ml) | 4.3 ± 2.5 | 6.5 ± 1.4 | < 0.001 |
Ghrelin (pmol/l) | 178.5 ± 89.6 | 300.9 ± 57.3 | < 0.001 |